General Information of Drug (ID: DMQ7AMI)

Drug Name
VAC18193
Indication
Disease Entry ICD 11 Status REF
Respiratory syncytial virus infection 1C80 Phase 3 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D1T2SQ

References

1 ClinicalTrials.gov (NCT05101486) A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years. U.S.National Institutes of Health.